ROCKWELL MEDICAL INC (RMTI) Stock Price, Quote, News and Overview
NASDAQ:RMTI - Nasdaq - US7743743004 - Common Stock - Currency: USD
RMTI Quote, Performance and Key Statistics
0.9923
-0.04 (-3.66%)
The current stock price of RMTI is 0.9923 USD. In the past month the price decreased by -7.26%. In the past year, price decreased by -46.36%.
RMTI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.53 | 44.26B | ||
| COO | COOPER COS INC/THE | 18.41 | 14.28B | ||
| ALGN | ALIGN TECHNOLOGY INC | 19.88 | 13.44B | ||
| SOLV | SOLVENTUM CORP | 12.51 | 12.87B | ||
| LNTH | LANTHEUS HOLDINGS INC | 12.2 | 5.59B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 26.44 | 5.58B | ||
| BLCO | BAUSCH + LOMB CORP | 26.06 | 4.42B | ||
| HAE | HAEMONETICS CORP/MASS | 15.65 | 3.44B | ||
| ICUI | ICU MEDICAL INC | 19.26 | 3.31B | ||
| XRAY | DENTSPLY SIRONA INC | 9.59 | 3.21B | ||
| UFPT | UFP TECHNOLOGIES INC | 28.69 | 1.81B | ||
| NEOG | NEOGEN CORP | 15.01 | 1.24B |
Related stock screener links
About RMTI
Company Profile
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 244 full-time employees. The firm develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The firm operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The company is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The firm manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Company Info
ROCKWELL MEDICAL INC
30142 Wixom Road
Wixom MICHIGAN 48393 US
CEO: Russell Ellison
Employees: 244
Phone: 18004493353
ROCKWELL MEDICAL INC / RMTI FAQ
What is the stock price of ROCKWELL MEDICAL INC today?
The current stock price of RMTI is 0.9923 USD. The price decreased by -3.66% in the last trading session.
What is the ticker symbol for ROCKWELL MEDICAL INC stock?
The exchange symbol of ROCKWELL MEDICAL INC is RMTI and it is listed on the Nasdaq exchange.
On which exchange is RMTI stock listed?
RMTI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ROCKWELL MEDICAL INC stock?
8 analysts have analysed RMTI and the average price target is 4.08 USD. This implies a price increase of 311.17% is expected in the next year compared to the current price of 0.9923. Check the ROCKWELL MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ROCKWELL MEDICAL INC worth?
ROCKWELL MEDICAL INC (RMTI) has a market capitalization of 33.91M USD. This makes RMTI a Nano Cap stock.
How many employees does ROCKWELL MEDICAL INC have?
ROCKWELL MEDICAL INC (RMTI) currently has 244 employees.
What are the support and resistance levels for ROCKWELL MEDICAL INC (RMTI) stock?
ROCKWELL MEDICAL INC (RMTI) has a support level at 0.97 and a resistance level at 1.02. Check the full technical report for a detailed analysis of RMTI support and resistance levels.
Is ROCKWELL MEDICAL INC (RMTI) expected to grow?
The Revenue of ROCKWELL MEDICAL INC (RMTI) is expected to decline by -32.1% in the next year. Check the estimates tab for more information on the RMTI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ROCKWELL MEDICAL INC (RMTI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RMTI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RMTI, evaluating the profitability, health, valuation and growth aspects
- ROCKWELL MEDICAL INC (RMTI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ROCKWELL MEDICAL INC (RMTI) Sales and EPS estimates to see what analysts future expectations are.
- ROCKWELL MEDICAL INC (RMTI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ROCKWELL MEDICAL INC (RMTI) Insider and Institutional Ownership to learn about the owners and their transactions.
- ROCKWELL MEDICAL INC (RMTI) Stock Chart to make your own analysis
- ROCKWELL MEDICAL INC (RMTI) Latest news and press-releases to stay up to date.
Does ROCKWELL MEDICAL INC (RMTI) stock pay dividends?
RMTI does not pay a dividend.
When does ROCKWELL MEDICAL INC (RMTI) report earnings?
ROCKWELL MEDICAL INC (RMTI) will report earnings on 2025-08-06.
What is the Short Interest ratio of ROCKWELL MEDICAL INC (RMTI) stock?
The outstanding short interest for ROCKWELL MEDICAL INC (RMTI) is 0.66% of its float. Check the ownership tab for more information on the RMTI short interest.
RMTI Technical Analysis
RMTI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to RMTI. The financial health of RMTI is average, but there are quite some concerns on its profitability.
RMTI Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.49% | ||
| ROE | -0.84% | ||
| Debt/Equity | 0.3 |
RMTI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to RMTI. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -701.43% and a revenue growth -32.1% for RMTI